Anti-aging Effects of Angelica keiskei Leaf Extract on Skeletal Muscle: Associations with NF-κB p65 and PGC-1α in a D-galactose Model
Open Access
- 21 October 2026
- journal article
- research article
- Published by SAGE Publications in Journal of Applied Pharmaceutical Science
- Vol. 16 (10) , 1133-1143
Abstract
Aging-associated skeletal muscle dysfunction is highly interlinked to chronic inflammation and mitochondrial dysregulation, with the suppression of PGC-1α representing a key molecular event. The use of natural phytochemicals to prevent aging-related pathological conditions has received increasing attention, including Angelica keiskei . This study examined the effects of A. keiskei leaf extract on skeletal muscle in a D-galactose (D-gal)-induced aging rat model, focusing on NF-κB p65 protein levels and PGC-1α-associated mitochondrial regulatory markers. Male rats were administered D-gal to induce accelerated aging and subsequently treated with A. keiskei extract. NF-κB p65 levels were assessed by ELISA, while the mRNA expression of Ppargc1a and its target gene Tfam , and mitochondrial antioxidants ( Sod2 , Txn1 , and Prdx1 ) in skeletal muscle tissue was quantified using real-time quantitative PCR. Administration of D-gal markedly increased NF-κB p65 protein levels, reduced the Ppargc1a and Tfam expression, and inhibited the mRNA expression of Sod2 , Txn1 , and Prdx1 , suggesting that inflammation impairs mitochondrial biogenesis and antioxidant defenses. Treatment with A. keiskei extract reduced NF-κB p65 protein levels, restored Ppargc1a mRNA expression, and partially restored antioxidant-related gene expression. These data indicate that A. keiskei extract attenuates the molecular characteristics of skeletal muscle aging through the suppression of inflammaging and the preservation of the PGC-1α-dependent mitochondrial regulatory pathways. This study collectively provides preliminary preclinical evidence that A. keiskei leaf extract may attenuate selected molecular and functional features of D-gal-induced skeletal muscle aging through changes consistent with reduced inflammatory signaling and preservation of PGC-1α-associated mitochondrial regulation.Keywords
This publication has 48 references indexed in Scilit:
- Epidemiology of sarcopenia: A narrative reviewOsteoporosis and Sarcopenia, 2025
- Sarcopenia-related traits and risk of falls in older adults: results from meta-analysis of cohort studies and Mendelian randomization analysesAging Clinical and Experimental Research, 2025
- Active biomonitoring of stream ecosystems: untargeted metabolomic and proteomic responses and free radical scavenging activities in musselsEcotoxicology, 2025
- Integrative insights into PNI: Low-grade chronic inflammation, skeletal muscle wasting, and brain impairmentsBrain, Behavior, & Immunity - Health, 2024
- GLP-2 ameliorates D-galactose induced muscle aging by IGF-1/Pi3k/Akt/FoxO3a signaling pathway in C2C12 cells and miceArchives of Gerontology and Geriatrics, 2024
- Association between resilience and frailty in older age: Findings from the Helsinki Birth Cohort StudyArchives of Gerontology and Geriatrics, 2023
- Persistent NF-κB activation in muscle stem cells induces proliferation-independent telomere shorteningCell Reports, 2021
- d-Galactose-induced oxidative stress and mitochondrial dysfunction in the cochlear basilar membrane: an in vitro aging modelBiogerontology, 2020
- d-Galactose-induced accelerated aging model: an overviewBiogerontology, 2019
- Angelica keiskei, an emerging medicinal herb with various bioactive constituents and biological activitiesArchives of Pharmacal Research, 2017